Gene Expression Nebulas
A data portal of transcriptomic profiles analyzed by a unified pipeline across multiple species

Gene Expression Nebulas

A data portal of transcriptome profiles across multiple species

PRJNA679844: Single-cell RNA-seq of air-liquid interface bronchioalveolar cells

Source: NCBI / GSE161934
Submission Date: Nov 20 2020
Release Date:
Update Date: Jan 29 2021

Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), may result in acute respiratory distress syndrome (ARDS), multi-organ failure and death. The alveolar epithelium is a major target of the virus, but representative models to study virus host interactions in more detail are currently lacking. Here, we describe a human 2D air-liquid interface culture system which was characterized by confocal-, electron-microscopy and single cell mRNA expression analysis. In this model, alveolar cells, but also basal cells and rare neuroendocrine cells, are grown from 3D self-renewing lung bud tip organoids. These cultures were readily infected by SARS-CoV-2 with mainly surfactant protein C-positive ATII-like cells being targeted. Consequently, significant viral titers were detected and mRNA expression analysis revealed induction of type I/III interferon response program. Treatment of these cultures with a low dose of interferon lambda dramatically reduced viral replication. Hence, these cultures represent an experimental model for SARS-CoV-2 infection and can be applied for drug screens.

Overall Design: The researchers have setup a bronchioalveolar model for studying COVID-19. scRNAseq was performed to characterize the model on air-liquid interface bronchioalveolar cells not infected with SARS-CoV-2.

GEN Datasets:
GEND000438
Strategy:
Species:
Tissue:
Healthy Condition:
Cell Type:
Cell Line:
Development Stage:
Protocol
Growth Protocol: Bronchioalveolar cultures were grown from human lung bud tip organoids and differentiated at air-liquid interface in transwell inserts in the presence of canalicular stage fetal lung mesenchymal cells in the basal compartment
Treatment Protocol: -
Extract Protocol: Cultures were incubated with TrypLE express for 20 min at 37 C 5% CO2 and cells were dissociated by pipetting. Cells were washes once in cold PBS and resuspended in 200 L ice-cold PBS. Ice-cold methanol was added dropwise to the cell pellet for fixation. Cells were stored at -20 C until further processing. Single-cell mRNA sequencing was performed according to standard 10x Genomics 3 V3.1 chemistry protocol. Prior to loading the cells on the 10x Chromium controller, cells were rehydrated in rehydration buffer and counted to assess cell concentration. Cells were loaded and the resulting sequencing libraries were prepared following standard 10x Genomics protocol.
Library Construction Protocol: The DNA libraries was paired-end sequenced on an Illumina Novaseq S4, with a 2x150 bp Illumina kit.
Sequencing
Molecule Type: Poly(A)+ RNA
Library Source:
Library Layout: PAIRED
Library Strand: -
Platform: ILLUMINA
Instrument Model: Illumina NovaSeq 6000
Strand-Specific: -
Samples
Basic Information:
Sample Characteristic:
Biological Condition:
Experimental Variables:
Protocol:
Sequencing:
Assessing Quality:
Analysis:
Data Resource GEN Sample ID GEN Dataset ID Project ID BioProject ID Sample ID Sample Name BioSample ID Sample Accession Experiment Accession Release Date Submission Date Update Date Species Race Ethnicity Age Age Unit Gender Source Name Tissue Cell Type Cell Subtype Cell Line Disease Disease State Development Stage Mutation Phenotype Case Detail Control Detail Growth Protocol Treatment Protocol Extract Protocol Library Construction Protocol Molecule Type Library Layout Strand-Specific Library Strand Spike-In Strategy Platform Instrument Model Cell Number Reads Number Gbases AvgSpotLen1 AvgSpotLen2 Uniq Mapping Rate Multiple Mapping Rate Coverage Rate
Publications
An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.
The EMBO journal . 2021-01-11 [PMID: 33283287]